These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 1896645

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cell-specific differences in activation of NF-kappa B regulatory elements of human immunodeficiency virus and beta interferon promoters by tumor necrosis factor.
    Lacoste J, D'Addario M, Roulston A, Wainberg MA, Hiscott J.
    J Virol; 1990 Oct; 64(10):4726-34. PubMed ID: 2204723
    [Abstract] [Full Text] [Related]

  • 4. Activation of nuclear factor kappa B in human neuroblastoma cell lines.
    Körner M, Tarantino N, Pleskoff O, Lee LM, Debré P.
    J Neurochem; 1994 May; 62(5):1716-26. PubMed ID: 8158122
    [Abstract] [Full Text] [Related]

  • 5. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage.
    Finnegan A, Roebuck KA, Nakai BE, Gu DS, Rabbi MF, Song S, Landay AL.
    J Immunol; 1996 Jan 15; 156(2):841-51. PubMed ID: 8543841
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phorbol ester reduces constitutive nuclear NF kappa B and inhibits HIV-1 production in mature human monocytic cells.
    Mufson RA, Myers C, Turpin JA, Meltzer M.
    J Leukoc Biol; 1992 Dec 15; 52(6):637-44. PubMed ID: 1464736
    [Abstract] [Full Text] [Related]

  • 8. Cross-linking of Fc gamma receptors activates HIV-1 long terminal repeat-driven transcription in human monocytes.
    Tsitsikov EN, Fuleihan R, McIntosh K, Scholl PR, Geha RS.
    Int Immunol; 1995 Oct 15; 7(10):1665-70. PubMed ID: 8562512
    [Abstract] [Full Text] [Related]

  • 9. Dual activity of pyrrolidine dithiocarbamate on kappa B-dependent gene expression in U937 cells: I. Regulation by the phorbol ester TPA.
    Watanabe K, Kazakova I, Furniss M, Miller SC.
    Cell Signal; 1999 Jul 15; 11(7):479-89. PubMed ID: 10405758
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Phosphatidylcholine hydrolysis activates NF-kappa B and increases human immunodeficiency virus replication in human monocytes and T lymphocytes.
    Arenzana-Seisdedos F, Fernandez B, Dominguez I, Jacqué JM, Thomas D, Diaz-Meco MT, Moscat J, Virelizier JL.
    J Virol; 1993 Nov 15; 67(11):6596-604. PubMed ID: 8411362
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activation of human immunodeficiency virus type 1 provirus in T-cells and macrophages is associated with induction of inducer-specific NF-kappa B binding proteins.
    Vlach J, Pitha PM.
    Virology; 1992 Mar 15; 187(1):63-72. PubMed ID: 1371030
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Stimulation of HIV type 1 gene expression and induction of NF-kappa B (p50/p65)-binding activity in tumor necrosis factor alpha-treated human fetal glial cells.
    Atwood WJ, Tornatore CS, Traub R, Conant K, Drew PD, Major EO.
    AIDS Res Hum Retroviruses; 1994 Oct 15; 10(10):1207-11. PubMed ID: 7848678
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
    Doerre S, Sista P, Sun SC, Ballard DW, Greene WC.
    Proc Natl Acad Sci U S A; 1993 Feb 01; 90(3):1023-7. PubMed ID: 8430069
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.